Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab

토픽 <svg xmlns="http://www.w3.org/2000/svg" width="14" height="14" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-down Header-module__hBw1pG__chevron" aria-hidden="true">

스마트머니 <svg xmlns="http://www.w3.org/2000/svg" width="14" height="14" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-down Header-module__hBw1pG__chevron" aria-hidden="true">

인사이트 <svg xmlns="http://www.w3.org/2000/svg" width="14" height="14" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-down Header-module__hBw1pG__chevron" aria-hidden="true">